Noticias de IMTX_US

Noticias del mercado

Últimas noticias sobre IMTX_US — 51 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: IMTX_US ✕ 51 resultados
21/04/2026 IMTX_US — Investing.com ES ← ILO
Immatics anuncia cuatro presentaciones orales en la reunión de ASCO Por Investing.com
21/04/2026 IMTX_US — TipRanks
Immatics Secures Four High-Profile Oral Slots for PRAME and Bispecific Programs at 2026 ASCO
21/04/2026 IMTX_US — Investing.com
Immatics announces four oral presentations at ASCO meeting
21/04/2026 IMTX_US — Stock Titan
Immatics (NASDAQ: IMTX) lines up four oral cancer therapy talks for ASCO 2026
21/04/2026 IMTX_US — GlobeNewswire ES ← EN
Immatics anuncia cuatro próximas presentaciones orales en todo
21/04/2026 IMTX_US — GlobeNewswire
Immatics Announces Four Upcoming Oral Presentations Across
21/04/2026 IMTX_US — Stock Titan
Four cancer studies put Immatics’ cell therapies on ASCO stage
18/04/2026 IMTX_US — simplywall.st
Immatics (IMTX) Is Up 7.1% After Pediatric PRAME TCR Remission Case And AACR Spotlight - Has The Bull Case Changed?
18/04/2026 IMTX_US — GuruFocus
Steffen Martin Walter Net Worth (2026)
18/04/2026 IMTX_US — MarketBeat
Immatics N.V. (NASDAQ:IMTX) Receives Average Recommendation of "Moderate Buy" from Analysts
18/04/2026 IMTX_US — Sahm
PRAME-directed Cell Therapy Using Immatics’ TCR Induces Deep and Durable Remission in Pediatric Patient with Advanced Metastatic Nephroblastoma
17/04/2026 IMTX_US — GuruFocus
Amie Elizabeth Krause Net Worth (2026)
17/04/2026 IMTX_US — GuruFocus
Immatics (IMTX) Showcases Pediatric Patient Breakthrough at AACR 2026
17/04/2026 IMTX_US — Investing News Network ES ← EN
La terapia celular dirigida por PRAME que utiliza TCR de Immatics induce una remisión profunda y duradera en pacientes pediátricos con nefroblastoma metastásico avanzado
17/04/2026 IMTX_US — TipRanks
Immatics Highlights PRAME-Targeted Cell Therapy Remission in Pediatric Kidney Cancer, Plans Pediatric Trial Expansion
17/04/2026 IMTX_US — Stock Titan
Pediatric remission case for Immatics (NASDAQ: IMTX) PRAME cell therapy
17/04/2026 IMTX_US — ChartMill
PRAME-directed Cell Therapy Using Immatics’ TCR Induces Deep and Durable Remission in Pediatric Patient with Advanced Metastatic Nephroblastoma
17/04/2026 IMTX_US — Stock Titan
Teen’s metastatic kidney cancer in remission 6 months after Immatics therapy
17/04/2026 IMTX_US — GuruFocus ES ← NL
Valor neto de Jordan Zeik Silverstein (2026)
17/04/2026 IMTX_US — GuruFocus
Cedrik Michael Britten Net Worth (2026)

Página 1 de 3

keyboard_arrow_up